Pharmaceutical

Frost and Sullivan Institute Honors Sustainability and Growth Trailblazers with Enlightened Growth Leadership Awards, 2023

SANTA CLARA, Calif., Sept. 19, 2023 /PRNewswire/ -- The Frost & Sullivan Institute is proud to present the 2023 Enlightened…

10 months ago

Avenir Wellness Solutions Announces Return of Stock Trading Back to OTCQB Market

SHERMAN OAKS, CA / ACCESSWIRE / September 19, 2023 / Avenir Wellness Solutions, Inc. (OTCQB:AVRW) ("Avenir" or the "Company"), a…

10 months ago

Poolbeg Pharma PLC Announces Immunomodulator I Patent Opposition Withdrawal

Important step in continued protection of Poolbeg's patent familyLONDON, UK / ACCESSWIRE / September 19, 2023 / Poolbeg Pharma (AIM:POLB)(OTCQB:POLBF)…

10 months ago

Bausch Health Announces CFO Transition Plan

LAVAL, QC / ACCESSWIRE / September 18, 2023 / Bausch Health Companies Inc. (NYSE/TSX:BHC) ("BHC" or the "Company") today announced…

10 months ago

GE HealthCare Awarded a $44 Million Grant to Develop Artificial Intelligence-Assisted Ultrasound Technology Aimed at Improving Outcomes in Low-and-Middle-Income Countries

Grant from Bill & Melinda Gates Foundation will facilitate development of AI-assisted applications and tools to enable healthcare professionals with…

10 months ago

Biocure Technology Inc. Enters into Exclusive Letter Agreement to Acquire Atriva Therapeutics GmbH in Reverse Takeover Transaction

Vancouver, British Columbia--(Newsfile Corp. - September 18, 2023) - Biocure Technology Inc. (CSE: CURE) ("CURE" or the "Company") announces that…

10 months ago

FloraWorks Announces Updated Analysis of Landmark Clinical Trial; CBN Shown Effective for Sleep

Radicle Science found TruCBN(TM) to significantly improve sleep outcomes in first-ever placebo-controlled trial of pure CBNPortland, Oregon--(Newsfile Corp. - September…

10 months ago

FSD Pharma announces Interim Results from First-in-Human Clinical Trial of Lucid-MS (Lucid-21-302) for Multiple Sclerosis; The Report Shows Compound to be Safe and Well Tolerated

TORONTO, ON / ACCESSWIRE / September 18, 2023 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ("FSD Pharma" or the "Company"), a biopharmaceutical…

10 months ago

TRIANA Biomedicines to Present at UBS Biotechnology Private Company Virtual Symposium

LEXINGTON, MA / ACCESSWIRE / September 18, 2023 / TRIANA Biomedicines, Inc. (TRIANA), an innovative biopharmaceutical company focused on advancing…

10 months ago

LAPIX Therapeutics Inc. Announces FDA Clearance of IND Application for its Treg-expanding Tim3/4 Agonist LPX-TI641 to Treat Multiple Sclerosis

BOSTON, Sept. 18, 2023 (GLOBE NEWSWIRE) -- LAPIX Therapeutics, Inc. (“LAPIX”), a biopharmaceutical company focused on developing novel, orally bioavailable…

10 months ago